A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)

Last updated: February 13, 2013
Sponsor: Janssen Research & Development, LLC
Overall Status: Active - Not Recruiting

Phase

3

Condition

Connective Tissue Diseases

Musculoskeletal Diseases

Joint Injuries

Treatment

N/A

Clinical Study ID

NCT01777399
CR017089
CNTO148JIA3001
2009-015019-42
  • Ages 2-18
  • Both

Study Design

Total Participants: 173
Study Start date:
December 01, 2010
Estimated Completion Date:
April 30, 2016

Connect with a study center

  • Buenos Aires,
    Argentina

    Site Not Available

  • Córdoba,
    Argentina

    Site Not Available

  • La Plata,
    Argentina

    Site Not Available

  • Rosario,
    Argentina

    Site Not Available

  • Bregenz,
    Austria

    Site Not Available

  • Wien,
    Austria

    Site Not Available

  • Brussels,
    Belgium

    Site Not Available

  • Gent,
    Belgium

    Site Not Available

  • Leuven,
    Belgium

    Site Not Available

  • Botucatu,
    Brazil

    Site Not Available

  • Curitiba,
    Brazil

    Site Not Available

  • Ribeirão Preto,
    Brazil

    Site Not Available

  • Rio De Janeiro,
    Brazil

    Site Not Available

  • Halifax, Nova Scotia
    Canada

    Site Not Available

  • Toronto, Ontario
    Canada

    Site Not Available

  • Helsinki,
    Finland

    Site Not Available

  • Oulu,
    Finland

    Site Not Available

  • Bad Bramstedt,
    Germany

    Site Not Available

  • Berlin,
    Germany

    Site Not Available

  • Bremen,
    Germany

    Site Not Available

  • Hamburg,
    Germany

    Site Not Available

  • Sankt Augustin,
    Germany

    Site Not Available

  • Vilnius,
    Lithuania

    Site Not Available

  • Ciudad De Mexico,
    Mexico

    Site Not Available

  • Monterrey,
    Mexico

    Site Not Available

  • San Luis Potosi,
    Mexico

    Site Not Available

  • Utrecht,
    Netherlands

    Site Not Available

  • Krakow,
    Poland

    Site Not Available

  • Lodz,
    Poland

    Site Not Available

  • Moscow,
    Russian Federation

    Site Not Available

  • Saint-Petersburg,
    Russian Federation

    Site Not Available

  • Samara,
    Russian Federation

    Site Not Available

  • Los Angeles, California
    United States

    Site Not Available

  • San Francisco, California
    United States

    Site Not Available

  • Augusta, Georgia
    United States

    Site Not Available

  • Boston, Massachusetts
    United States

    Site Not Available

  • Durham, North Carolina
    United States

    Site Not Available

  • Cincinatti, Ohio
    United States

    Site Not Available

  • Portland, Oregon
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.